Berotralstat Treatment in Children With Hereditary Angioedema

Clinical trial NCT05453968 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05453968
Sponsor: BioCryst Pharmaceuticals
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hereditary Angioedema Pediatric

Start date: 2022-10-25
Primary completion: 2024-09-11
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.